The clinical performance is complex and often involves multiple systemic burdens. Early identification and standardised clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological evaluation.
The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Treatment plans for smoking and management of multiple malignancies require individualized development, usually including multidimensional management, including drug therapy, rehabilitation, and regular follow-up visits. In recent years, with the development of treatment-oriented, immune-regulatory treatments and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved.
Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of smoking-type multiple myeloma. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.